Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial

Pharmacogenomics Journal

Volumn 15, Issue 6, 2015, Pages 488-495

  Ellis, K L ^a   Zhou, Y ^b   Beshansky, J R ^c   Ainehsazan, E ^e   Selker, H P ^a   Cupples, L A ^d   Huggins, G S ^a   Peter, I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d REGIS COLLEGE   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT EXPORT PUMP; GLUCOSE; INSULIN; POTASSIUM; GLUCOSE BLOOD LEVEL;

ABCB11 GENE; ACUTE CORONARY SYNDROME; ADCYAP1 GENE; ADULT; AHCYL1 GENE; AKAP12 GENE; ALLELE; ARFGEF2 GENE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNAH5 GENE; DOUBLE BLIND PROCEDURE; FEMALE; GENE; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE INSULIN POTASSIUM INFUSION; HEART INFARCTION SIZE; HUMAN; INFUSION; LCA5 GENE; MAGI1 GENE; MAJOR CLINICAL STUDY; MALE; METABOLITE; MODIFIER GENE; NDRG4 GENE; PRIORITY JOURNAL; PTCSC3 GENE; PTPRG GENE; RANDOMIZED CONTROLLED TRIAL; SETX GENE; STRADA GENE; TAS1R3 GENE; THERAPY EFFECT; TREATMENT RESPONSE; XPO4 GENE; CLINICAL TRIAL; GENETIC VARIATION; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ALLELES; BLOOD GLUCOSE; DOUBLE-BLIND METHOD; FEMALE; GENETIC VARIATION; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; POTASSIUM; TREATMENT OUTCOME;

EID: 84947488726     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2015.10     Document Type: Article

References (42)

1. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994; 267: H1785-H1794
2. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res 1983; 52: 515-526
3. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS et al. Atp synthesis during low-flow ischemia: Influence of increased glycolytic substrate. Circulation 2000; 101: 2090-2096
4. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991; 68: 466-481
5. Selker HP, Raitt MH, Schmid CH, Laks MM, Beshansky JR, Griffith JL et al. Timedependent predictors of primary cardiac arrest in patients with acute myocardial infarction. Am J Cardiol 2003; 91: 280-286
6. Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D'Agostino RB et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the immediate randomized controlled trial. JAMA 2012; 307: 1925-1933
7. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-1754
8. Chutkow WA, Samuel V, Hansen PA, Pu J, Valdivia CR, Makielski JC et al. Disruption of sur2-containing k(atp) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci USA 2001; 98: 11760-11764
9. Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H et al. The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metabolism 2014; 63: 127-136
10. Ranasinghe AM, McCabe CJ, Quinn DW, James SR, Pagano D, Franklyn JA et al. How does glucose insulin potassium improve hemodynamic performance? Evidence for altered expression of beta-Adrenoreceptor and calcium handling genes. Circulation 2006; 114: I239-I244
11. Ellis KL, Zhou Y, Beshansky JR, Ainehsazan E, Yang Y, Selker HP et al. Genetic variation at glucose and insulin trait loci and response to glucose-insulinpotassium (gik) therapy: the immediate trial. Pharmacogenomics J 2014; 15: 55-62
12. Selker HP, Beshansky JR, Griffith JL, D'Agostino RB, Massaro JM, Udelson JE et al. Study design for the immediate myocardial metabolic enhancement during initial assessment and treatment in emergency care (immediate) trial: a double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J 2012; 163: 315-322
13. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012; 8: e1002793
14. Grove ML, Yu B, Cochran BJ, Haritunians T, Bis JC, Taylor KD et al. Best practices and joint calling of the humanexome beadchip: The charge consortium. PLoS ONE 2013; 8: e68095
15. Manning AK, LaValley M, Liu CT, Rice K, An P, Liu Y et al. Meta-Analysis of geneenvironment interaction: Joint estimation of snp and snp x environment regression coefficients. Genet Epidemiol 2011; 35: 11-18
16. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 2005; 95: 221-227
17. Selker HP, Udelson JE, Massaro JM, Ruthazer R, D'Agostino RB, Griffith JL et al. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (gik) in patients with suspected acute coronary syndromes (from the immediate [immediate myocardial metabolic enhancement during initial assessment and treatment in emergency care] trial). Am J Cardiol 2014; 113: 1599-1605
18. Grossman AN, Opie LH, Beshansky JR, Ingwall JS, Rackley CE, Selker HP. Glucoseinsulin-potassium revived: Current status in acute coronary syndromes and the energy-depleted heart. Circulation 2013; 127: 1040-1048
19. Ellis JM, Mentock SM, Depetrillo MA, Koves TR, Sen S, Watkins SM et al. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy. Mol Cell Biol 2011; 31: 1252-1262
20. Zhao X, Ye Q, Xu K, Cheng J, Gao Y, Li Q et al. Single-nucleotide polymorphisms inside microrna target sites influence the susceptibility to type 2 diabetes. J Hum Genet 2013; 58: 135-141
21. Phillips CM, Goumidi L, Bertrais S, Field MR, Cupples LA, Ordovas JM et al. Genenutrient interactions with dietary fat modulate the association between genetic variation of the acsl1 gene and metabolic syndrome. J Lipid Res 2010; 51: 1793-1800
22. Bouchard C, Sarzynski MA, Rice TK, Kraus WE, Church TS, Sung YJ et al. Genomic predictors of the maximal o(2) uptake response to standardized exercise training programs. J Appl Physiol (1985) 2011; 110: 1160-1170
23. Johnson CO, Lemaitre RN, Fahrenbruch CE, Hesselson S, Sotoodehnia N, McKnight B et al. Common variation in fatty acid genes and resuscitation from sudden cardiac arrest. Circ Cardiovasc Genet 2012; 5: 422-429
24. Lipowsky G, Bischoff FR, Schwarzmaier P, Kraft R, Kostka S, Hartmann E et al. Exportin 4: A mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J 2000; 19: 4362-4371
25. Luchessi AD, Cambiaghi TD, Hirabara SM, Lambertucci RH, Silveira LR, Baptista IL et al. Involvement of eukaryotic translation initiation factor 5a (eif5a) in skeletal muscle stem cell differentiation. J Cell Physiol 2009; 218: 480-489
26. Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK et al. The unique hypusine modification of eif5a promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 2010; 120: 2156-2170
27. Hwang HH, Moon PG, Lee JE, Kim JG, Lee W, Ryu SH et al. Identification of the target proteins of rosiglitazone in 3t3-l1 adipocytes through proteomic analysis of cytosolic and secreted proteins. Mol Cells 2011; 31: 239-246
28. Gu HF. Genetic variation screening and association studies of the adenylate cyclase activating polypeptide 1 (adcyap1) gene in patients with type 2 diabetes. Hum Mutat 2002; 19: 572-573
29. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al. A genomewide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345
30. Marroni F, Pfeufer A, Aulchenko YS, Franklin CS, Isaacs A, Pichler I et al. A genomewide association scan of rr and qt interval duration in 3 european genetically isolated populations: The eurospan project. Circ Cardiovasc Genet 2009; 2: 322-328
31. Vangipurapu J, Stancakova A, Pihlajamaki J, Kuulasmaa TM, Kuulasmaa T, Paananen J et al. Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6, 733 non-diabetic finnish men. Diabetologia 2011; 54: 563-571
32. Chen WM, Erdos MR, Jackson AU, Saxena R, Sanna S, Silver KD et al. Variations in the g6pc2/abcb11 genomic region are associated with fasting glucose levels. J Clin Invest 2008; 118: 2620-2628
33. Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, Serizawa M et al. Common variants at the gck, gckr, g6pc2-Abcb11 and mtnr1b loci are associated with fasting glucose in two asian populations. Diabetologia 2010; 53: 299-308
34. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J et al. Common variants at 10 genomic loci influence hemoglobin a(1)(c) levels via glycemic and nonglycemic pathways. Diabetes 2010; 59: 3229-3239
35. Qu X, Jia H, Garrity DM, Tompkins K, Batts L, Appel B et al. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 2008; 317: 486-496
36. Pfeufer A, Sanna S, Arking DE, Muller M, Gateva V, Fuchsberger C et al. Common variants at ten loci modulate the qt interval duration in the qtscd study. Nat Genet 2009; 41: 407-414
37. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K et al. Common variants at ten loci influence qt interval duration in the qtgen study. Nat Genet 2009; 41: 399-406
38. Hamilton JA, Vairo G, Lingelbach SR. Activation and proliferation signals in murine macrophages: Stimulation of glucose uptake by hemopoietic growth factors and other agents. J Cell Physiol 1988; 134: 405-412
39. Wieland SJ, Chou RH, Gong QH. Macrophage-colony-stimulating factor (csf-1) modulates a differentiation-specific inward-rectifying potassium current in human leukemic (hl-60) cells. J Cell Physiol 1990; 142: 643-651
40. Cai BZ, Gong DM, Liu Y, Pan ZW, Xu CQ, Bai YL et al. Homocysteine inhibits potassium channels in human atrial myocytes. Clin Exp Pharmacol Physiol 2007; 34: 851-855
41. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK et al. A Catalog of Published Genome-Wide Association Studies. Available at: www. genome.gov/gwastudies. Accessed [March 2014].
42. Gibbons RJ. Tc-99m spect sestamibi for the measurement of infarct size. J Cardiovasc Pharmacol Ther 2011; 16: 321-331